← Back to headlines
AstraZeneca's Imfinzi Regimen Shows Success in Late-Stage Liver Cancer Trial
AstraZeneca announced positive results from a late-stage clinical trial for its Imfinzi regimen, demonstrating a win in the treatment of liver cancer.
2 Apr, 11:24 — 2 Apr, 11:24
Sources
Showing 1 of 1 sources
